Medicare Enrolled
Dr. Joseph De La Garza, M.D.
Gynecologic Oncology Physician · San Antonio, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. De La Garza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De La Garza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. De La Garza
Dr. Joseph De La Garza is a gynecologic oncology physician in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. De La Garza performed 1,731 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. De La Garza received a total of $285,164 from 49 pharmaceutical and/or device companies across 448 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De La Garza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 19% volume in TX
$285,164 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,731
Medicare services
Top 19% in TX for gynecologic oncology physician
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
338 | $10 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
337 | $59 | $250 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
332 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
322 | $8 | $20 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 180 | $20 | $128 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $118 | $565 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
43 | $96 | $707 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $81 | $368 |
| Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less. |
17 | $694 | $3,096 |
| Endoscopic biopsy and removal of abdominal lymph nodes A procedure to examine and remove lymph nodes in the abdominal cavity using an endoscope. The endoscope allows the provider to access the area through a small incision. |
13 | $196 | $1,842 |
| Intraoperative lymph node imaging Imaging performed during surgery to visualize lymph nodes. |
13 | $154 | $874 |
| Central venous port insertion A surgical procedure to place a small reservoir under the skin for long-term access to the bloodstream. The device is connected to a vein to allow for repeated medication administration or blood draws. |
12 | $246 | $4,202 |
| Endometrial biopsy or polyp removal A procedure to collect a tissue sample from the uterine lining or remove a polyp using a thin, lighted tube inserted through the cervix. |
12 | $176 | $3,661 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
12 | $11 | $57 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
12 | $14 | $69 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.5% high complexity
2.9% medium
94.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$285,164
Total received (2018-2024)
Avg $40,738/year across 7 years
Top 3% in TX for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
448
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$58,000
2023
$30,003
2022
$41,674
2021
$32,447
2020
$15,322
2019
$42,785
2018
$64,932
Payments by company (2024)
PFIZER INC.
$22,908
INTUITIVE SURGICAL, INC.
$21,393
AstraZeneca Pharmaceuticals LP
$6,849
Genmab U.S., Inc.
$6,229
Musculoskeletal Transplant Foundation Inc.
$305
Myriad Genetic Laboratories, Inc.
$127
Dilon Technologies, Inc.
$60
Davol Inc.
$49
Merck Sharp & Dohme LLC
$47
CONMED Corporation
$33
Top 3 companies account for 88.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$137,773
Seagen Inc.
$49,918
PFIZER INC.
$22,908
INTUITIVE SURGICAL, INC.
$21,393
Merck Sharp & Dohme Corporation
$18,924
Intuitive Surgical, Inc.
$17,012
Merck Sharp & Dohme LLC
$6,625
Genmab U.S., Inc.
$6,229
Myriad Genetic Laboratories, Inc.
$445
Janssen Biotech, Inc.
$427
Genentech USA, Inc.
$333
Memic Innovative Surgery Inc.
$314
Musculoskeletal Transplant Foundation Inc.
$305
Amgen Inc.
$270
Clovis Oncology, Inc.
$254
Ethicon US, LLC
$236
Janssen Pharmaceuticals, Inc
$155
Exelixis Inc.
$122
Baxter Healthcare
$122
TESARO, Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$116
Janssen Products, LP
$100
Verastem, Inc.
$89
Dilon Technologies, Inc.
$87
Bayer HealthCare Pharmaceuticals Inc.
$79
Incyte Corporation
$72
Novartis Pharmaceuticals Corporation
$67
Eisai Inc.
$58
Kyowa Kirin, Inc.
$56
Celgene Corporation
$53
Davol Inc.
$49
Daiichi Sankyo Inc.
$45
Lilly USA, LLC
$39
Puma Biotechnology, Inc.
$38
Hologic, LLC
$36
Boston Scientific Corporation
$35
Taiho Oncology, Inc.
$34
CONMED Corporation
$33
TELA Bio, Inc.
$31
Sobi, Inc
$22
ARRAY BIOPHARMA INC
$21
SANOFI-AVENTIS U.S. LLC
$20
Helsinn Therapeutics (U.S.), Inc.
$19
AtriCure, Inc.
$17
EMD Serono, Inc.
$16
Alnylam Pharmaceuticals Inc.
$15
GENZYME CORPORATION
$12
Alexion Pharmaceuticals, Inc.
$12
Spectrum Pharmaceuticals Inc.
$11
Top 3 companies account for 73.9% of all-time payments
Associated products mentioned in payments ›
AIRSEAL · AKYNZEO · APTIMA · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · Anovo Surgical System · Avastin · BRACANALYSIS CDX · Bavencio · Blincyto · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · ECHELON ENDOPATH · ELITEK · EMEND · Epkinly · Erleada · FLOSEAL · Folotyn · GARDASIL · GIVLAARI · HEMOBLAST BELLOWS · Halaven · Hominis Surgical System · INJECTAFER · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · Lonsurf · MYCHOICE CDX · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PADCEV · POTELIGEO · Phasix Mesh · Pomalyst · RYDAPT · Revlimid · Rubraca · SANCUSO · Stivarga · TAGRISSO · TECENTRIQ · TIVDAK · Tivdak · ULTOMIRIS · Vectibix · WATCHMAN · XARELTO · XGEVA · ZEJULA · ZYTIGA · myChoice CDx
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gynecologic oncology physicians in nearby ZIP areas
12
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. De La Garza is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. De La Garza experienced with comprehensive metabolic blood panel?
Based on Medicare claims data, Dr. De La Garza performed 338 comprehensive metabolic blood panel services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. De La Garza receive payments from pharmaceutical companies?
Yes. Dr. De La Garza received a total of $285,164 from 49 companies across 448 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De La Garza's costs compare to other gynecologic oncology physicians in San Antonio?
Dr. De La Garza's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De La Garza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Gynecologic Oncology Physicians in San Antonio
Browse gynecologic oncology physicians in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Gynecologic Oncology Physicians in TX
Gynecologic oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gynecologic Oncology Physicians in TX
Which TX gynecologic oncology physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology